Organs on Chips Market
Organs on Chips Market - Global Industry Assessment & Forecast
Segments Covered
- By Type Liver, Heart, Lung, Other Organ Types
- By Application Drug Discovery, Toxicology Research, Other Applications
- By End User Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Other End Users
- By Region Latin America, North America, Europe, Asia Pacific, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 35.78 Million |
Revenue 2030: | USD 254.69 Million |
Revenue CAGR (2023 - 2030): | 27.80% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Sr. No. | Offering | Report Coverage |
1. | Market Size | In terms of Revenue (USD Million) |
2. | Historic Data | 2017 to 2021 |
3. | Forecast Data | 2023 to 2030 |
4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
5. | Market Attractiveness Analysis | Yes |
6. | Segment Analysis | Maximum Segments |
7. | Regional Coverage | 5 Regions |
8. | Country Coverage | Top 22 Countries |
9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
10. | Porter’s Five Forces Analysis | Yes. |
11. | Value Chain Analysis | Yes |
12. | PEST Analysis | Yes |
13. | Regulatory Landscape | Yes |
14. | Technology Landscape | Yes |
15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
16. | Top startups to watch out for | Yes |
17. | Top 3 Trends to Watch | Yes |
18. | Top 3 Strategies Followed by Major Players | Yes |
19. | Top 3 Predictions by Vantage Market Research | Yes |
20. | Discussion Guide | Yes |
21. | Key Primary Respondents - VERBATIM | Yes |
22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
23. | Others/Miscellaneous |
FAQ
Frequently Asked Question
What is the global demand for Organs on Chips in terms of revenue?
-
The global Organs on Chips valued at USD 35.78 Million in 2022 and is expected to reach USD 254.69 Million in 2030 growing at a CAGR of 27.80%.
Which are the prominent players in the market?
-
The prominent players in the market are AxoSim Inc., BiomimX SRL, Elveflow, Emulate Inc., Hurel Corporation, InSphero AG, MIMETAS BV, Nortis Inc., Tara Biosystems Inc., and TissUse GmbH.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 27.80% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Organs on Chips include
- Advancements in Technology
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Organs on Chips in 2022.